Experts
Opyl (ASX: OPL) are a Melbourne based company with client service and development teams in both Australia and the US.
Opyl provides biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Experts
Scopo’s Health Powerplays: Show me the (grant) money
News
Rise and Shine: What you need to know before the ASX opens
Tech
Opyl clinical trial prediction tool completes COVID-19 proof-of-concept
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s marching ahead this morning?
News
10 at 10: These ASX stocks are ballooning upwards this morning
Tech
Turnaround story: Opyl’s new look
Tech
Opyl’s artificial intelligence will change clinical trials forever
Health & Biotech
Opyl is eyeing a 30pc revenue hike in 2021
Experts
Scopo’s health powerplays: Markets are getting back to normal
News
Rise and Shine: What you need to know before the ASX opens
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
StockDoc: Data collected through social media could be a game changer for the healthcare sector
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Experts
